Company Overview
- Website
- redarrowtx.com
- Phone
- (617) 256-2008
- Employees
- 4
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Recent News & Media
A Randomized Phase II Trial of Gemcitabine, Nab-Paclitaxel, Cisplatin with or without a Medically Supervised Ketogenic Diet for Patients with Metastatic Pancreatic Cancer
- Jun 9, 2025
- medrxiv.org
A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer
- Jan 9, 2025
- sciencedirect.com
Nivolumab in Patients With Advanced or Metastatic Malignancies, Including Rare Cancers: Results of CheckMate 627, an Adaptive Basket Design Clinical Trial
- Nov 27, 2024
- ascopubs.org
An IL‐12‐Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors
- Oct 21, 2024
- pmc.ncbi.nlm.nih.gov
Polymeric cloak stabilizes cytokine complex to generate tumor-targeted nanosuperagonist
- Oct 3, 2024
- eurekalert.org
Red Arrow Therapeutics Inc. closes $4.5M Seed Extension round
- Apr 23, 2024
- prnewswire.com
Company Leadership
Red Arrow Therapeutics Industry Tags
Companies Similar to Red Arrow Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Red Arrow Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |